Claude drug cases WATCH
For life-science AI teams, the cases show where agents are entering real workflows beyond molecule generation. They do not establish that Claude caused clinical success, and the reported gains should be treated as partner case evidence until independently validated.
Next stepWait for independent controlled results or progression into human trials before using these cases for model or workflow selection.